These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28164650)

  • 21. Distribution of hepatitis C virus genotypes in Croatia--a 10 year retrospective study of four geographic regions.
    Vince A; Iscić-Bes J; Zidovec Lepej S; Baća-Vrakela I; Bradarić N; Kurelac I; Vince DB
    Coll Antropol; 2006 Dec; 30 Suppl 2():139-43. PubMed ID: 17508487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between histologic staging, hepatitis C virus genotypes and clinical features in HCV chronic hepatitis: evidence of a new pattern.
    Di Tommaso L; Macchia S; Morandi L; Leoncini S; Pession A; Dal Monte PR; Foschini MP
    Int J Surg Pathol; 2003 Jul; 11(3):197-204. PubMed ID: 12894351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B.
    Rosen HR; Chou S; Sasaki AW; Gretch DR
    Am J Gastroenterol; 1999 Oct; 94(10):3015-9. PubMed ID: 10520862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.
    Bouscaillou J; Champagnat J; Luhmann N; Avril E; Inaridze I; Miollany V; Labartkava K; Kirtadze I; Butsashvili M; Kamkamidze G; Pataut D
    Int J Drug Policy; 2014 Sep; 25(5):871-8. PubMed ID: 24529802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping.
    Liu CH; Liang CC; Liu CJ; Lin CL; Su TH; Yang HC; Chen PJ; Chen DS; Kao JH
    J Clin Microbiol; 2015 May; 53(5):1754-7. PubMed ID: 25740780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.
    Mourez T; Decroos A; Goria O; Montialoux H; De Oliveira F; Larrat S; Plantier JC; Riachi G
    J Med Virol; 2018 May; 90(5):994-997. PubMed ID: 29350410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.
    Kurbanov F; Tanaka Y; Chub E; Maruyama I; Azlarova A; Kamitsukasa H; Ohno T; Bonetto S; Moreau I; Fanning LJ; Legrand-Abravanel F; Izopet J; Naoumov N; Shimada T; Netesov S; Mizokami M
    J Infect Dis; 2008 Nov; 198(10):1448-56. PubMed ID: 18928375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancy between HCV structural and non structural genes in Georgian genotype two patients.
    Tsertsvadze T; Karchava M; Sharvadze L; Gatserelia L; Dolmazashvili E
    Georgian Med News; 2014 Oct; (235):74-8. PubMed ID: 25416222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6.
    Ku KS; Chodavarapu RK; Martin R; Miller MD; Mo H; Svarovskaia ES
    J Clin Microbiol; 2016 Jul; 54(7):1835-1841. PubMed ID: 27147726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.
    Nainan OV; Alter MJ; Kruszon-Moran D; Gao FX; Xia G; McQuillan G; Margolis HS
    Gastroenterology; 2006 Aug; 131(2):478-84. PubMed ID: 16890602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus recombinants are rare even among intravenous drug users.
    Viazov S; Ross SS; Kyuregyan KK; Timm J; Neumann-Haefelin C; Isaeva OV; Popova OE; Dmitriev PN; El Sharkawi F; Thimme R; Michailov MI; Roggendorf M
    J Med Virol; 2010 Feb; 82(2):232-8. PubMed ID: 20029799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cases of hepatitis C virus infection with 2i/2a recombination genotype in the Lanzhou area and effects of related genetic variations on interferon alpha response].
    Zhang W; Du S; Yang J; Qu Y; Mao W; Li J; Li C; Tian S; Gong Y; Rao H; Kong W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):484-9. PubMed ID: 25203797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of mixed genotype infections in Polish patients with hepatitis C.
    Gowin E; Bereszyńska I; Adamek A; Kowala-Piaskowska A; Mozer-Lisewska I; Wysocki J; Michalak M; Januszkiewicz-Lewandowska D
    Int J Infect Dis; 2016 Feb; 43():13-16. PubMed ID: 26701819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural prevalence of hepatitis C virus (HCV) variants resistant to protease and polymerase inhibitors in patients infected with HCV genotype 1 in Tunisia.
    Aissa Larousse J; Trimoulet P; Recordon-Pinson P; Papuchon J; Azzouz MM; Ben Mami N; Cheikh I; Triki H; Fleury H
    J Med Virol; 2014 Aug; 86(8):1350-9. PubMed ID: 24760718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genotyping of HCV isolates from different populations in Shanghai by using second generation line probe assay].
    Jiang W; Gu S; Hu Y
    Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):29-30. PubMed ID: 10366982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Punjab Province in Pakistan and a phylogenetic analysis.
    Aziz H; Raza A; Murtaza S; Waheed Y; Khalid A; Irfan J; Samra Z; Athar MA
    Int J Infect Dis; 2013 Apr; 17(4):e247-53. PubMed ID: 23183233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).
    Aguilera A; Navarro D; Rodríguez-Frias F; Viciana I; Martínez-Sapiña AM; Rodríguez MJ; Martró E; Lozano MC; Coletta E; Cardeñoso L; Suárez A; Trigo M; Rodríguez-Granjer J; Montiel N; de la Iglesia A; Alados JC; Vegas C; Bernal S; Fernández-Cuenca F; Pena MJ; Reina G; García-Bujalance S; Echevarria MJ; Benítez L; Pérez-Castro S; Ocete D; García-Arata I; Guerrero C; Rodríguez-Iglesias M; Casas P; García F
    J Viral Hepat; 2017 Sep; 24(9):725-732. PubMed ID: 28248445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: Identification of recombinant HCV genotype 1b-2b by viral sequencing in two patients with treatment failure, who responded to re-treatment with sofosbuvir and daclatasvir.
    Uribe-Noguez LA; Ocaña-Mondragón A; Mata-Marín JA; Cázares-Cortázar A; Ribas-Aparicio RM; Gómez-Torres ME; Gaytán-Martínez J; Martínez-Rodríguez ML
    J Infect Chemother; 2018 Nov; 24(11):928-931. PubMed ID: 29773440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan.
    Yokoyama K; Takahashi M; Nishizawa T; Nagashima S; Jirintai S; Yotsumoto S; Okamoto H; Momoi MY
    Arch Virol; 2011 Sep; 156(9):1591-601. PubMed ID: 21643787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.